3/4
08:06 am
qure
uniQure (NASDAQ: QURE) had its price target lowered by analysts at Mizuho from $10.00 to $7.00. They now have a "neutral" rating on the stock.
Low
Report
uniQure (NASDAQ: QURE) had its price target lowered by analysts at Mizuho from $10.00 to $7.00. They now have a "neutral" rating on the stock.
3/1
11:03 pm
qure
uniQure (NASDAQ: QURE) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
uniQure (NASDAQ: QURE) was upgraded by analysts at StockNews.com to a "sell" rating.
3/1
02:44 pm
qure
uniQure (NASDAQ: QURE) had its price target lowered by analysts at HC Wainwright from $30.00 to $25.00. They now have a "buy" rating on the stock.
Low
Report
uniQure (NASDAQ: QURE) had its price target lowered by analysts at HC Wainwright from $30.00 to $25.00. They now have a "buy" rating on the stock.
2/29
09:23 am
qure
uniQure (NASDAQ: QURE) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $8.00 price target on the stock.
Medium
Report
uniQure (NASDAQ: QURE) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $8.00 price target on the stock.
2/28
07:05 am
qure
uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
Low
Report
uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
1/19
08:04 am
qure
uniQure (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
uniQure (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
1/16
09:13 am
qure
uniQure (NASDAQ: QURE) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $28.00 price target on the stock.
Medium
Report
uniQure (NASDAQ: QURE) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $28.00 price target on the stock.
1/5
12:18 pm
qure
GeNeuro Names Anke Post as Chief Medical Officer, Following Retirement of David Leppert who Becomes a Consultant to GeNeuro [Yahoo! Finance]
Low
Report
GeNeuro Names Anke Post as Chief Medical Officer, Following Retirement of David Leppert who Becomes a Consultant to GeNeuro [Yahoo! Finance]